Hui Zhang Shuliang Zhao Zhijun Cao
10.3389/fimmu.2022.1001055
Front Immunol
2022 Oct 28;13:1001055.
epstein–barr virus immunosuppression inflammatory bowel disease lymphoproliferative diseases viral colitis
CC BY
https://pubmed.ncbi.nlm.nih.gov/36389673/
Colitis, Ulcerative / therapy Epstein-Barr Virus Infections Inflammatory Bowel Diseases / complications Inflammatory Bowel Diseases / diagnosis Inflammatory Bowel Diseases / drug therapy Lymphomatoid Granulomatosis
Colitis, Ulcerative / therapy Epstein-Barr Virus Infections Inflammatory Bowel Diseases / complications Inflammatory Bowel Diseases / diagnosis Inflammatory Bowel Diseases / drug therapy Lymphomatoid Granulomatosis Review Research Support, Non-U.S. Gov't Herpesvirus 4, Human Humans
PMC9651941
36389673
Impact of Epstein-Barr virus infection in patients with inflammatory bowel disease
2022